NEW YORK (GenomeWeb News) – British Columbia has provided nearly C$2.2 million (US$2.1 million) to the BC Cancer Agency to buy three genome sequencers that will be installed in the Michael Smith Genome Sciences Centre (GSC).
Western Economic Diversification Canada (WD), which provided the funding, said on Friday that the program also will support a new business outreach coordinator who will aim to increase the GSC's work with industry.
WD said that the new sequencing and outreach will help the GSC win large-scale research projects, lower the cost of sequencing for local industries and the broader life sciences community, and make it easier to retain and lure researchers that use genome sequencing in their cancer studies.
BC Cancer Agency VP of Research Samuel Abraham said in a statement that the funding will provide GSC scientists with "new sequencing technology that is vital for continuing to harness the power of genomics research."
The GSC is one of 15 research programs operated by the BC Cancer Agency, and is the largest sequencing facility in Canada.